Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 5/2011

01.10.2011 | Original Article

Four-year follow-up of chronic neuronopathic Gaucher disease in Europeans using a modified severity scoring tool

verfasst von: Elin Haf Davies, Eugen Mengel, Anna Tylki-Szymanska, G. Kleinotiene, Joerg Reinke, Ashok Vellodi

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

In 2007, the European Task Force for neuronopathic Gaucher disease (NGD) published a review of 55 patients across four countries. Although some observations were possible, analysis was difficult due to the absence of a systematic way of assessing patients. In response to this, a Severity Scoring Tool (SST) was devised to offer a systematic means of assessing the neurological presentation seen. The SST has been modified (mSST) and is a valid tool for monitoring neurological progression. This review describes disease status and progression of neurological manifestations in a cohort of 39 chronic NGD patients across three European countries over a period of 4 years, using the mSST.
Literatur
Zurück zum Zitat Davies E, Erikson A, Collin-Histed T, Mengel E, Tylki-Szymanska A, Vellodi A (2007a) Outcome of type III Gaucher disease on enzyme replacement therapy: review of 55 cases. J Inherit Metab Dis 30(6):935–42PubMedCrossRef Davies E, Erikson A, Collin-Histed T, Mengel E, Tylki-Szymanska A, Vellodi A (2007a) Outcome of type III Gaucher disease on enzyme replacement therapy: review of 55 cases. J Inherit Metab Dis 30(6):935–42PubMedCrossRef
Zurück zum Zitat Davies E, Surtees R, DeVile C, Schoon I, Vellodi A (2007b) A severity scoring tool to assess the neurological features of neuronopathic Gaucher disease. J Inherit Metab Dis 30(5):768–82. 5, Epub 2007 Sep 16PubMedCrossRef Davies E, Surtees R, DeVile C, Schoon I, Vellodi A (2007b) A severity scoring tool to assess the neurological features of neuronopathic Gaucher disease. J Inherit Metab Dis 30(5):768–82. 5, Epub 2007 Sep 16PubMedCrossRef
Zurück zum Zitat Schiffmann R, Fitzgibbon EJ, Harris C, DeVile C, Davies EH, Abel L, van Schaik I, Timmons M, Ries M, Vellodi A (2008) A randomized controlled trial of miglustat in Gaucher disease type 3. Ann Neurol 64(5):514–22PubMedCrossRef Schiffmann R, Fitzgibbon EJ, Harris C, DeVile C, Davies EH, Abel L, van Schaik I, Timmons M, Ries M, Vellodi A (2008) A randomized controlled trial of miglustat in Gaucher disease type 3. Ann Neurol 64(5):514–22PubMedCrossRef
Zurück zum Zitat Tylki-Szymańska A, Vellodi A, El-Beshlawy A, Cole JA, Kolodny E (2010) Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry. J Inherit Metab Dis 33(4):339–46PubMedCrossRef Tylki-Szymańska A, Vellodi A, El-Beshlawy A, Cole JA, Kolodny E (2010) Neuronopathic Gaucher disease: demographic and clinical features of 131 patients enrolled in the International Collaborative Gaucher Group Neurological Outcomes Subregistry. J Inherit Metab Dis 33(4):339–46PubMedCrossRef
Zurück zum Zitat Vellodi A, Bembi B, de Villemeur TB, Collin-Histed T, Erikson A, Mengel E, Rolfs A, Tylki-Szymanska A (2001) Neuronopathic Gaucher Disease Task Force of the European Working Group on Gaucher Disease. 2001 Management of neuronopathic Gaucher disease: a European consensus. J Inherit Metab Dis 24(3):319–27PubMedCrossRef Vellodi A, Bembi B, de Villemeur TB, Collin-Histed T, Erikson A, Mengel E, Rolfs A, Tylki-Szymanska A (2001) Neuronopathic Gaucher Disease Task Force of the European Working Group on Gaucher Disease. 2001 Management of neuronopathic Gaucher disease: a European consensus. J Inherit Metab Dis 24(3):319–27PubMedCrossRef
Zurück zum Zitat Vellodi A, Tylki-Szymanska A, Davies EH, Kolodny E, Bembi B, Collin-Histed T, Mengel E, Erikson A, Schiffmann R (2009) Management of neuronopathic Gaucher disease: revised recommendations. J Inherit Metab Dis 32(5):660–4, Aug 5PubMedCrossRef Vellodi A, Tylki-Szymanska A, Davies EH, Kolodny E, Bembi B, Collin-Histed T, Mengel E, Erikson A, Schiffmann R (2009) Management of neuronopathic Gaucher disease: revised recommendations. J Inherit Metab Dis 32(5):660–4, Aug 5PubMedCrossRef
Metadaten
Titel
Four-year follow-up of chronic neuronopathic Gaucher disease in Europeans using a modified severity scoring tool
verfasst von
Elin Haf Davies
Eugen Mengel
Anna Tylki-Szymanska
G. Kleinotiene
Joerg Reinke
Ashok Vellodi
Publikationsdatum
01.10.2011
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 5/2011
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-011-9347-z

Weitere Artikel der Ausgabe 5/2011

Journal of Inherited Metabolic Disease 5/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.